In this episode, Advarra's IRB Chairs Luke Gelinas and Amanda Higley discuss hot topics in clinical research, including cannabis studies, returning research results, and data ownership.

What will be the 2022 trends in clinical research? In this episode, Advarra's James Riddle and Wendy Tate forecast what is coming up for clinical trials and clinical research in 2022, including changes in study design, gene therapy innovations, decentralized clinical trials, consolidation of research sites, and increased knowledge about clinical trials and research in the community.

In this episode, Advarra's James Riddle and Willie Muehlhausen, Co-Founder of SAFIRA Clinical Research, discuss the growth of decentralized clinical trial technology and how IRBs evolved to account for technology advancements.

In this episode, Wendy Tate chats with Tiffany Danielle Pineda and Brian Sevier to discuss what the University of Florida Clinical and Translational Science Institute has accomplished to increase diversity, equity, and access in clinical research.

The Common Rule provides a framework for ethical conduct of clinical research involving human participants. In this episode, Advarra’s Lauren Hartsmith and Connie Cullity dive into what the Common Rule is and what it means for sponsors, investigators, IRBs, and the protection of research participants.

Discussions with:

Wendy Tate

PhD, MS, GStat

Senior Clinical Research Strategist

Advarra

Dylan Rosser

Executive Director, Global Development Operations

Amgen

Discussions with:

James Riddle

MCSE, CIP, CPIA, CRQM

VP of Research Services & Strategic Consulting

Advara

Barbara Schneider

Ph.D., MBA

Executive Director of Biostatistical Services

Advarra

Patient advocates and industry innovators Aidan Gannon of Advarra and Jessica Perry of Moderna discuss patient centricity in clinical research, examine COVID-19's impact on patient-centric conduct, and investigate evolving expectations of trial participants.

In this episode, Jake Meyer and Candi Barlow review results from Advarra's recent survey and discuss study activation success strategies for sites. Our experts share their thoughts on budget negotiation from how to make do with a tight budget to taking less conventional approaches.

The Gene Therapy market is accelerating at unprecedented speed, with expected growth globally of 16.6% between 2020-2027, but it hasn’t been an easy road. In this episode, Advarra’s Daniel Eisenman talks with Dr. Adam Soloff and Dr. Paul Gulig for an enriching discussion about the growth, misconceptions, and promise of gene therapy.